Founders Fund Growth Management
Latest statistics and disclosures from Founders Fund Growth Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are AFRM, ABCL, OPEN, and represent 100.00% of Founders Fund Growth Management's stock portfolio.
- Founders Fund Growth Management has $83M in assets under management (AUM), dropping by 125.03%.
- Central Index Key (CIK): 0001853431
Tip: Access up to 7 years of quarterly data
Positions held by Founders Fund Growth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Founders Fund Growth Management
Founders Fund Growth Management holds 3 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Affirm Hldgs Com Cl A (AFRM) | 96.5 | $80M | 1.6M | 49.14 |
|
|
| Abcellera Biologics (ABCL) | 2.8 | $2.3M | 407k | 5.71 |
|
|
| Opendoor Technologies (OPEN) | 0.7 | $560k | 125k | 4.48 |
|
Past Filings by Founders Fund Growth Management
SEC 13F filings are viewable for Founders Fund Growth Management going back to 2021
- Founders Fund Growth Management 2023 Q4 filed Feb. 14, 2024
- Founders Fund Growth Management 2023 Q3 filed Nov. 14, 2023
- Founders Fund Growth Management 2023 Q2 filed Aug. 14, 2023
- Founders Fund Growth Management 2023 Q1 filed May 15, 2023
- Founders Fund Growth Management 2022 Q4 filed Feb. 14, 2023
- Founders Fund Growth Management 2022 Q3 filed Nov. 14, 2022
- Founders Fund Growth Management 2022 Q2 filed Aug. 15, 2022
- Founders Fund Growth Management 2022 Q1 filed May 16, 2022
- Founders Fund Growth Management 2021 Q4 filed Feb. 14, 2022